World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 13 January 2015
Main ID:  ISRCTN17551624
Date of registration: 23/06/2008
Prospective Registration: Yes
Primary sponsor: Cardiff University (UK)
Public title: Evidence into Practice: evaluating a Child-centred intervention for diabetes medicine management
Scientific title:
Date of first enrolment: 01/02/2009
Target sample size: 200
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN17551624
Study type:  Interventional
Study design:  Pragmatic randomised controlled trial (Quality of life)  
Phase: 
Countries of recruitment
United Kingdom
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name: Anne    Williams
Address:  Nursing, Health and Social Care Research Centre School of Nursing & Midwifery Studies Eastgate House 35-43 Newport Road CF24 0AB Cardiff United Kingdom
Telephone: +44 (0)29 2091 7816
Email: awglanrhyd@aol.com
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Children aged 6 - 18 years, either sex
2. Type one diabetes

Exclusion criteria: 1. Severe learning difficulties
2. Significant social problems
3. Needle phobias


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Type one diabetes
Nutritional, Metabolic, Endocrine
Insulin-dependent diabetes mellitus
Intervention(s)
The investigation is a mixed-method study informed by the 'Promoting Action on Research Implementation in Health Services' (PARIHS) framework which has been widely used to inform design and evaluation of evidence-into-practice initiatives.

To meet our objectives which are aligned with the phases of the Medical Research Council (MRC) framework for randomised controlled trials (RCTs) of complex interventions we have designed a four-stage study:
Stage 1: Review and, where appropriate, undertake further work to identify types/formats of information most likely to assist age-appropriate decision-making/choices related to children/young people with type one diabetes. Duration: April 2008 to October 2008.
Stage 2: Construct an exemplar information resource, piloting for variations as necessary. Duration: November 2008 to October 2009.
Stage 3: Conduct a pragamatic evaluation to assess utility, acceptability effectiveness and cost effectiveness of the information resource. Duration: November 2009 to June 2010.
Stage 4: Undertake data synthesis and comparative analysis. Duration: July 2009 to March 2011.

The intervention lasts for 8 months with a follow-up at 3 months from baseline and 3 months from first follow-up.
Primary Outcome(s)
Choice of outcomes is guided by Health Technology Assessment (HTA) commissioned systematic reviews recommending that HbA1c (glycaemic control measure) is not the appropriate primary outcome on which to assess benefits of an intervention designed to more directly effect behaviour/self-management. Therefore, the primary outcome measure is diabetes self-efficacy and quality-of-life using the Diabetes Pediatric Quality of Life Inventory (PedsQol).

Outcomes will be measured at baseline, 3 months (follow-up 1) and 6 months (follow-up 2).
Secondary Outcome(s)
1. HbA1c
2. Generic quality of life
3. Routinely collected NHS/child-held data costs
4. Service use
5. Acceptability/utility

Outcomes will be measured at baseline, 3 months (follow-up 1) and 6 months (follow-up 2).
Secondary ID(s)
0001653
Source(s) of Monetary Support
National Institute for Health Research (NIHR) (UK) - Service Delivery and Organisation (SDO) Programme (ref: 0001653)
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history